China vaccine against Ebola started testing in humans. The experiment was conducted at the Military medical Institute of the PRC.
The vaccine is made on the basis of the mutated gene and targeting the strain, which is widespread in West Africa. Currently the vaccine is in the form of chilled powder, which can keep stable for 2 weeks at temperatures up to plus 37 degrees Celsius. This allows you to rely on industrial production and subsequent implementation in West Africa, according to Chinese professionals, according to TASS.
Previously researchers have successfully completed study on the effects of vaccines against Ebola. After studies in humans scientists announced that the results that have demonstrated created to combat the virus product, are encouraging.
The experience took place in several frontiers. Initially, volunteers were divided into 2 groups: she got a big dose of the vaccine, and another is small. The results showed that antibodies produced more representatives of the 1st group. The results of the study were published in scientific medical journal New England Journal of Medicine.
In the composition of the vaccine is at the gene level, the modified virus from chimpanzees, is capable of carrying on its surface a non-infectious protein of Ebola virus. According to the doctors, vaccine trial will be held in 4 stages, the study is not yet completed. 2 and 3 milestones will be held in West Africa - directly there will be explained how the vaccine is safe. Also, it remains to be seen how long it can protect the body.
sections: Society, World News |